Choose from Fda Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials collection ...

The update is meant “to ensure that cat and dog food manufacturers are aware of information about the new H5N1 hazard associated with their pet food products,” FDA officials said. A concern ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

29 weekly enforcement report, the FDA classified the recall of eight Cal ... and should dispose of them or return them to us for a full refund," the release said. Christine Rousselle is a ...

3 in food and ingested drugs have until January 15, 2027, and January 18, 2028, respectively, to reformulate their products, according to the FDA. Foods imported to the United States also must ...

The Food and Drug Administration has classified a recall of 60 different doughnut products to its second-highest level, the agency announced earlier this week in an update to its website.

Brian King, director of the FDA’s Center of Tobacco Products, said Wednesday that reducing the amount of nicotine in tobacco products to the levels proposed in the new rule should significantly ...

Tempest Therapeutics (TPST) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track Designation, FTD, to amezalpat, an oral, small molecule, selective PPAR antagonist for ...

The substance gives a cherry-red hue to certain foods and medicines. The FDA ban comes on the cusp of potentially bigger changes in the food industry under the incoming Trump administration.

The U.S. Food and Drug Administration (FDA) has proposed a new rule requiring bold, easy-to-read nutrition labels on the front of food and beverage packages. These labels, which would highlight ...

Nektar (NKTR) Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years of age and older with ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in positive trial results that could set it up for a full approval.